RBC Capital analyst Randall Stanicky notes Akorn (NASDAQ: AKRX) has received approval for generic Voltaren Gel.Stanicky notes the approval comes ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE